Tweets
Benefits with receiving anabolic agents upfront before antiresoprtives (as opposed to other way around). Shame about lack of access to this sequence currently
@RheumNow #ACR22 #osteoporosis https://t.co/S2ttbrVaab
Julian Segan @JulianSegan ( View Tweet )
3 years 8 months ago
Low likelihood of syndesmophyte formation in PsA but is more likely assoc'd w/ axial involvement radiographically + high CRP. Abs 1014 #ACR22 @RheumNow https://t.co/M5Tc0fd64s https://t.co/e25gwVQKeo
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
DISCOVER 1 & 2: Subanalysis of GUS in 181 pts w/ Axial PsA and imaging confirmed SI
GUS improves BASDAI, mBASDAI, spinal pain, morning stiffness, and ASDAS from W8 to W24
W24 Response rates BASDAI50 38% BASDAI70 20%
https://t.co/MrS8atrIOI
Abs#1035 #ACR22 @Rheumnow https://t.co/wMDkO1Qak9
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 8 months ago
Most important point from the Great Debate on treating pre-RA.
Are we really treating to prevent RA or are we simply delaying RA onset?
I don't think there is enough data to treat pre-clinical RA with our current arsenal of DMARDs.
What would you do?
@RheumNow #ACR22
Robert B Chao, MD @doctorRBC ( View Tweet )
3 years 8 months ago
The Great Debate! Should you treat pre-clinical RA?
ACPA+ ~40% did not convert to clinical RA
RF+/ACPA+ least likely to seroconvert to negative
@RheumNow #ACR22 https://t.co/djVPKDdWjz
Robert B Chao, MD @doctorRBC ( View Tweet )
3 years 8 months ago
Dr. Talabi: Progestin-only has⬇️thrombotic risk vs. estrogen👇
‼️Safety signal for DMPA/depo shot bec. might be more prothrombotic vs. other progestin methods; addt'l studies needed; recommend to avoid in aPL+ for now
#ACR22 @Rheumnow https://t.co/pQe5H8wqvi
sheila @RHEUMarampa ( View Tweet )
3 years 8 months ago
"Less than 1 in 6 rheumatology guideline recommendations are informed by head-to-head RCTs." #ACR22 abst#1284 @rheumnow Comparative Effectiveness Randomized Controlled Trials in Rheumatology Guidelines https://t.co/l5NzzcHRSA
TheDaoIndex @KDAO2011 ( View Tweet )
3 years 8 months ago
Most prevalent locations of enthesitis on the global SpA population are the lumbar spinous processes, the thoracic spinous processes & Achilles tendon. MEI & MASES best capturing axSpA enthesitis. MEI & SPARCC best in pSpA & PsA. Abs 1004 #ACR22 @RheumNow https://t.co/6IbusqHI5d https://t.co/5y5NFthyJz
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 8 months ago
Tofacitinib in new-onset PMR:
Nice mechanistic data - all the right things line up - leading to promising proof-of-concept study (EAST PMR)
Plenty to tease apart here but real promise to explore in bigger studies
ABST1107 #ACR22 @RheumNow https://t.co/s4ts7lrVtZ
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
Dr Iyer shares how ROSCE can teach trainees #telerheumatology using video visits:
☝️ Relevant to career, enhanced self-directed learning
☝️Accdg to ROSCE results, improvement needed on telemed focused exams
🤓Video ROSCE as T-L strat, eval
#ACR22 @RheumNow #MedEd @rheumarhyme https://t.co/kZXMrbwtzW
sheila @RHEUMarampa ( View Tweet )
3 years 8 months ago
Coming off denosumab is very tricky! No such thing as drug holiday given high risk of rebound fractures. Need to cap with BP but duration uncertain.
@RheumNow #ACR22 #osteoporosis https://t.co/a4VNAI2D49
Julian Segan @JulianSegan ( View Tweet )
3 years 8 months ago
Was my pleasure to chat with Prof Eder @lihi_eder about her fantastic abstract #1007 about dietary interventions in PsA- DIPSA study!
Catch our interview now on below link 🌟
#ACR22 @RheumNow
https://t.co/liwc38wErT
Patricia Harkins @DrTrishHarkins ( View Tweet )
3 years 8 months ago
